½ÃÀ庸°í¼­
»óǰÄÚµå
1741473

¼¼°èÀÇ ÇÏÀÌ¿£µå ¼¿·Î¹Í½º ½ÃÀå : Á¦Ç° À¯Çüº°, ¿ëµµº°, ±â¼úº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº°

High End Cellomics Market, By Product Type, By Application, By Technology, By End User, By Geography

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Coherent Market Insights | ÆäÀÌÁö Á¤º¸: ¿µ¹® | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

ÇÏÀÌ¿£µå ¼¿·Î¹Í½º ½ÃÀåÀº 2025³â¿¡´Â 46¾ï 4,000¸¸ ´Þ·¯, 2032³â¿¡´Â 85¾ï 4,000¸¸ ´Þ·¯¿¡ À̸£°í, 2025-2032³â ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)Àº 9.1%¸¦ ³ªÅ¸³¾ Àü¸ÁÀÔ´Ï´Ù.

º¸°í¼­ ¹üÀ§ º¸°í¼­ »ó¼¼
±âÁØ ¿¬µµ 2024³â 2025³â ½ÃÀå ±Ô¸ð 46¾ï 4,000¸¸ ´Þ·¯
½ÇÀû µ¥ÀÌÅÍ 2020-2024³â ¿¹Ãø ±â°£ 2025-2032³â
¿¹Ãø ±â°£(2025-2032³â) CAGR 9.10% 2032³â °¡Ä¡ ¿¹Ãø 85¾ï 4,000¸¸ ´Þ·¯

ÇÏÀÌ¿£µå ¼¿·Î¹Í½º ½ÃÀåÀº Å©°Ô ¼ºÀåÇϰí ÀÖÀ¸¸ç, ¼¼Æ÷ ºÐ¼® ¹× ¿¬±¸ ºÐ¾ß¿¡¼­ Áß¿äÇÑ ÃÊÁ¡ÀÌ µÇ°í ÀÖ½À´Ï´Ù. ÇÏÀÌ¿£µå ¼¿·Î¹Í½º´Â ºÐÀÚ ¼öÁØ¿¡¼­ ¼¼Æ÷ ¿¬±¸¿¡ »ç¿ëµÇ´Â ÷´Ü ±â¼ú°ú Àåºñ¸¦ ¸»ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ±â¼úÀº °úÇÐÀÚ¿Í ¿¬±¸ÀÚµéÀÌ ¼¼Æ÷ÀÇ ±¸Á¶, ±â´É, µ¿¿ªÇÐÀ» ºÐ¼®ÇÒ ¼ö ÀÖ°Ô ÇÏ¿© ½Å¾à°³¹ß, Áúº´ Áø´Ü, ¸ÂÃãÀÇ·á µî ´Ù¾çÇÑ ºÐ¾ß¿¡¼­ Áß¿äÇÑ ÁøÀüÀ» °¡Á®¿É´Ï´Ù.

ÇÏÀÌ¿£µå ¼¿·Î¹Í½º´Â ¼¼Æ÷ ±â¹Ý ¿¬±¸¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿Í ¼¼Æ÷ ÇÁ·Î¼¼½ºÀÇ Á¤¹ÐÇϰí Á¤È®ÇÑ ºÐ¼®ÀÇ Çʿ伺À¸·Î ÀÎÇØ °¢±¤¹Þ°í ÀÖ½À´Ï´Ù. °íÇØ»óµµ Çö¹Ì°æ ¹× °íÇÔ·® ½ºÅ©¸®´×°ú °°Àº À̹Ì¡ ±â¼úÀÇ ¹ßÀüÀº ÇÏÀÌ¿£µå ¼¿·Î¹Í½º ½ÃÀåÀÇ ¼ºÀå¿¡ Å©°Ô ±â¿©Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÀΰøÁö´É°ú ¸Ó½Å·¯´× ¾Ë°í¸®ÁòÀÇ ÅëÇÕÀº º¹ÀâÇÑ ¼¼Æ÷ µ¥ÀÌÅÍÀÇ ºÐ¼®°ú ÇØ¼®¿¡ Çõ¸íÀ» ÀÏÀ¸Ä×½À´Ï´Ù.

½ÃÀå ¿ªÇÐ:

ÇÏÀÌ¿£µå ¼¿·Î¹Í½º ½ÃÀåÀº °³ÀÎ ¸ÂÃãÇü ÀÇ·á¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿Í ½Å¾à °³¹ß ¹× ½ÃÀå °³Ã´¿¡ ´ëÇÑ °ü½É Áõ°¡ µî ¿©·¯ ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. ¾Ï, ½ÉÇ÷°ü Áúȯ°ú °°Àº ¸¸¼º ÁúȯÀÇ À¯º´·ü Áõ°¡´Â ÷´Ü ¼¼Æ÷ ºÐ¼® ±â¼ú¿¡ ´ëÇÑ ¼ö¿ä¸¦ ´õ¿í Áõ°¡½Ã۰í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Á¦¾àȸ»ç ¹× »ý¸í°øÇÐ ±â¾÷ÀÇ ¿¬±¸°³¹ß Ȱµ¿¿¡ ´ëÇÑ ÅõÀÚµµ ½ÃÀå °³Ã´¿¡ Å©°Ô ±â¿©Çϰí ÀÖ½À´Ï´Ù.

¿¹¸¦ µé¾î, 2023³â 10¿ù 26ÀÏ, ¿¬±¸ ±â¼ú ±â¾÷ A4cellÀº 310¸¸ ´Þ·¯ÀÇ ´ë±Ô¸ð ÅõÀÚ¸¦ ¹ßÇ¥ÇÏ¿´½À´Ï´Ù. ÀÌ Áß¿äÇÑ ÅõÀÚ´Â ¶óÀÌºê ´ÜÀÏ ¼¼Æ÷ ºÐ¼® ºÐ¾ß¸¦ ¿ÏÀüÈ÷ º¯È­½ÃŰ´Â Ã˸ÅÁ¦ ¿ªÇÒÀ» ÇÒ °ÍÀÔ´Ï´Ù. À̹ø ÅõÀÚ´Â ÁÖ·Î ¿¬±¸ °³¹ß ³ë·ÂÀ» °­È­Çϰí, °íµµ·Î ¼÷·ÃµÈ °úÇÐÀÚ¿Í ¿£Áö´Ï¾î¸¦ ´Ã¸®°í, »ì¾ÆÀÖ´Â ´ÜÀÏ ¼¼Æ÷¿¡ ¼û°ÜÁø ½Åºñ¸¦ ¹àÈ÷´Â °ÍÀ» ¸ñÇ¥·Î ÇÏ´Â ÃÖ÷´Ü ±â¼ú °³¹ßÀ» °¡¼ÓÈ­ÇÏ´Â µ¥ »ç¿ëµÉ ¿¹Á¤ÀÔ´Ï´Ù.

±×·¯³ª ÇÏÀÌ¿£µå ¼¿·Î¹Í½º ½ÃÀå ¿ª½Ã ¹®Á¦¿¡ Á÷¸éÇØ ÀÖ½À´Ï´Ù. ÷´Ü ¼¼Æ÷ ºÐ¼® ÀåºñÀÇ Á¶´Þ ¹× À¯Áö º¸¼ö¿¡ µû¸¥ ³ôÀº ºñ¿ëÀÌ Æ¯È÷ ½ÅÈï±¹ ½ÃÀå¿¡¼­ ½ÃÀå °³Ã´¿¡ À庮ÀÌ µÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, º¹ÀâÇÑ ¼¼Æ÷ µ¥ÀÌÅ͸¦ ´Ù·ç°í ºÐ¼®ÇÏ´Â µ¥ ¼÷·ÃµÈ Àü¹®°¡°¡ ºÎÁ·ÇÏ¿© ÇÏÀÌ¿£µå ¼¿·Î¹Í½º ±â¼úÀÇ º¸±ÞÀ» ÀúÇØÇϰí ÀÖ½À´Ï´Ù.

ÀÌ·¯ÇÑ µµÀü¿¡µµ ºÒ±¸Çϰí, ÇÏÀÌ¿£µå ¼¼Æ÷ÇÐ ½ÃÀå¿¡´Â ¸¹Àº ¼ºÀå ±âȸ°¡ ÀÖ½À´Ï´Ù. ´ÜÀÏ ¼¼Æ÷ ½ÃÄö½Ì ¹× °ø°£ Àü»çü ºÐ¼®°ú °°Àº »õ·Î¿î ¼¼Æ÷ ºÐ¼® ±â¼úÀÇ ÃâÇöÀº ¼¼Æ÷ ¸ÞÄ¿´ÏÁò¿¡ ´ëÇÑ ´õ ¸¹Àº ޱ¸¿Í ÀÌÇØÀÇ ±æÀ» ¿­¾îÁÙ °ÍÀÔ´Ï´Ù. ¶ÇÇÑ, ¸ÖƼ¿À¹Í½º µ¥ÀÌÅÍ ºÐ¼®ÀÇ ÅëÇÕ°ú Çõ½ÅÀûÀÎ À̹Ì¡ ¾ç½ÄÀÇ °³¹ßÀº ½ÃÀå È®´ëÀÇ À¯¸ÁÇÑ ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù.

º» Á¶»çÀÇ ÁÖ¿ä Æ¯Â¡

  • ¼¼°èÀÇ ÇÏÀÌ¿£µå ¼¿·Î¹Í½º ½ÃÀå¿¡ ´ëÇØ Á¶»ç ºÐ¼®ÇßÀ¸¸ç, ½ÃÀå ±Ô¸ð¿Í 2024³âÀ» ±âÁØ ¿¬µµ·Î ÇÏ¿© 2025-2032³âÀÇ ¿¹Ãø ±â°£ µ¿¾ÈÀÇ CAGR(¿¬Æò±Õ ¼ºÀå·ü) µîÀÇ Á¤º¸¸¦ Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.
  • ´Ù¾çÇÑ ½ÃÀå ºÎ¹®ÀÇ ÀáÀçÀû ¼öÀÍ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇϰí, ÇÏÀÌ¿£µå ¼¿·Î¹Í½º ½ÃÀå¿¡ ´ëÇÑ ¸Å·ÂÀûÀÎ ÅõÀÚ Á¦¾È ¸ÅÆ®¸¯½º¸¦ Á¦°øÇÕ´Ï´Ù.
  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ, ÀúÇØ¿äÀÎ, ±âȸ, ½ÅÁ¦Ç° Ãâ½Ã ¹× ½ÂÀÎ, ½ÃÀå µ¿Çâ, Áö¿ª Àü¸Á, ÇÏÀÌ¿£µå ¼¿·Î¹Í½º ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷ÀÌ Ã¤ÅÃÇÑ °æÀï Àü·« µî¿¡ ´ëÇÑ ÁÖ¿ä °íÂûÀ» Á¦°øÇÕ´Ï´Ù.
  • ¼¼°è ÇÏÀÌ¿£µå ¼¿·Î¹Í½º ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷ ÇÁ·ÎÆÄÀÏÀ» ¼ö·ÏÇÏ¿© ±â¾÷ ¹è°æ, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÁÖ¿ä ½ÇÀû, À繫 ½ÇÀû, Àü·« µîÀ» ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù.
  • ½á¸ðÇǼŠ»çÀ̾ðƼÇÈ, ´Ù³ªÇã, ÆÛŲ¿¤¸Ó, BD, ¹ÙÀÌ¿À·¡µå ·¡¹ö·¯Å丮½º, ¾ÖÁú·±Æ® Å×Å©³î·ÎÁö, ÀÏ·ç¹Ì³ª, ·ç¹Ì³Ø½º, ¸ÓÅ© KGaA, GEÇコÄɾî, ºê·çÄ¿, ³ª³ë½ºÆ®¸µ Å×Å©³î·ÎÁö½º, 10xÁ¦³ë¹Í½º, Ç÷çÀ̵ñ, ¼¿½Ã, ¹öŬ¸®¶óÀÌÆ®, ¹ÐÅ×´Ï ¹ÙÀÌ¿ÀÅØ, ¹ÙÀÌ¿ÀÅ×Å©³×, ½ºÇǾîÇ÷çÀ̵ñ½º, ¹ÙÀÌ¿À³ª³ëÁ¦³ë¹Í½º, ¹ÙÀÌ¿ÀÅ×Å©³×, ¹ÙÀÌ¿ÀÅ×Å©³×, ½ºÇǾîÇ÷çÀ̵ñ½º µî ¼¿½Ã, ¹öŬ¸® ¶óÀÌÃ÷, ¹Ì¸£Å×´Ï ¹ÙÀÌ¿ÀÅØ, ¹ÙÀÌ¿À³ª³ëÁ¦³ë¹Í½º, ¹ÙÀÌ¿ÀÅ×Å©³×, ½ºÇǾîÇ÷çµñ½º µî ÁÖ¿ä ±â¾÷À» ¸Á¶óÇϰí ÀÖ½À´Ï´Ù.
  • ÀÌ º¸°í¼­ÀÇ ÅëÂû·ÂÀ» ÅëÇØ ¸¶ÄÉÆÃ ´ã´çÀÚ¿Í °æ¿µÁøÀº Á¦Ç° Ãâ½Ã, ¾÷±×·¹À̵å, ½ÃÀå È®´ë, ¸¶ÄÉÆÃ Àü·«¿¡ ´ëÇÑ Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù.
  • ÀÌ º¸°í¼­´Â ÅõÀÚÀÚ, °ø±Þ¾÷ü, Á¦Ç° Á¦Á¶¾÷ü, À¯Åë¾÷ü, ½Å±Ô Âü°¡ÀÚ, À繫 ºÐ¼®°¡ µî ÇÏÀÌ¿£µå ¼¿·Î¹Í½º ½ÃÀåÀÇ ´Ù¾çÇÑ ÀÌÇØ°ü°èÀÚ¸¦ ´ë»óÀ¸·Î ÇÕ´Ï´Ù.
  • ÀÌÇØ°ü°èÀÚµéÀº ¼¼°è ÇÏÀÌ¿£µå ¼¿·Î¹Í½º ½ÃÀå ºÐ¼®¿¡ »ç¿ëµÈ Àü·« ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ÀÌÀÍÀ» ¾òÀ» ¼ö ÀÖÀ¸¸ç, ÀÇ»ç°áÁ¤À» ½±°Ô ³»¸± ¼ö ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¸ñÀû°ú ÀüÁ¦Á¶°Ç

  • Á¶»ç ¸ñÀû
  • ÀüÁ¦Á¶°Ç
  • ¾à¾î

Á¦2Àå ½ÃÀå Àü¸Á

  • º¸°í¼­ ¼³¸í
    • ½ÃÀå Á¤ÀÇ¿Í ¹üÀ§
  • ÁÖ¿ä ¿ä¾à
  • Coherent Opportunity Map(COM)

Á¦3Àå ½ÃÀå ¿ªÇÐ, ±ÔÁ¦, µ¿Ç⠺м®

  • ½ÃÀå ¿ªÇÐ
  • ¿µÇ⠺м®
  • ÁÖ¿ä ÇÏÀ̶óÀÌÆ®
  • ±ÔÁ¦ ½Ã³ª¸®¿À
  • Á¦Ç° ¹ß¸Å/½ÂÀÎ
  • PEST ºÐ¼®
  • PORTER ºÐ¼®
  • ÀμöÇÕº´(M&A) ½Ã³ª¸®¿À

Á¦4Àå ¼¼°èÀÇ ÇÏÀÌ¿£µå ¼¿·Î¹Í½º ½ÃÀå - Äڷγª¹ÙÀÌ·¯½º(COVID-19) ÆÒµ¥¹ÍÀÇ ¿µÇâ

  • COVID-19 ¿ªÇÐ
  • °ø±ÞÃø°ú ¼ö¿äÃø ºÐ¼®
  • °æÁ¦¿¡ ´ëÇÑ ¿µÇâ

Á¦5Àå ¼¼°èÀÇ ÇÏÀÌ¿£µå ¼¿·Î¹Í½º ½ÃÀå : Á¦Ç° À¯Çüº°, 2020³â-2032³â

  • ±â±â
  • ½Ã¾à ¹× ¼Ò¸ðǰ
  • ¼ÒÇÁÆ®¿þ¾î
  • ¼­ºñ½º

Á¦6Àå ¼¼°èÀÇ ÇÏÀÌ¿£µå ¼¿·Î¹Í½º ½ÃÀå : ¿ëµµº°, 2020³â-2032³â

  • Drug Discovery
  • ¾Ï ¿¬±¸
  • ½Å°æ°úÇÐ
  • Áٱ⼼Æ÷ ¿¬±¸ ¹× Àç»ýÀÇ·á
  • ¸ÂÃãÇü ÀÇ·á
  • ±âŸ

Á¦7Àå ¼¼°èÀÇ ÇÏÀÌ¿£µå ¼¿·Î¹Í½º ½ÃÀå : ±â¼úº°, 2020³â-2032³â

  • Çö¹Ì°æ °Ë»ç
  • À¯¼¼Æ÷ºÐ¼®±â
  • ´Ü¼¼Æ÷ À¯ÀüüÇÐ
  • Áú·®ºÐ¼®
  • Â÷¼¼´ë ½ÃÄö½Ì
  • ±âŸ

Á¦8Àå ¼¼°èÀÇ ÇÏÀÌ¿£µå ¼¿·Î¹Í½º ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°, 2020³â-2032³â

  • ¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö ¹× Á¦¾àȸ»ç
  • º´¿ø ¹× Áø´Ü½ÇÇè½Ç
  • ¼öŹ¿¬±¸±â°ü
  • ±âŸ

Á¦9Àå ¼¼°èÀÇ ÇÏÀÌ¿£µå ¼¿·Î¹Í½º ½ÃÀå : Áö¿ªº°, 2020³â-2032³â

  • ºÏ¹Ì
      • ¹Ì±¹
      • ij³ª´Ù
  • À¯·´
      • ¿µ±¹
      • µ¶ÀÏ
      • ÀÌÅ»¸®¾Æ
      • ÇÁ¶û½º
      • ½ºÆäÀÎ
      • ·¯½Ã¾Æ
      • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
      • Áß±¹
      • ÀϺ»
      • Àεµ
      • ASEAN
      • È£ÁÖ
      • Çѱ¹
      • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä«
      • ºê¶óÁú
      • ¸ß½ÃÄÚ
      • ¾Æ¸£ÇîÆ¼³ª
      • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
  • Áßµ¿
      • GCC
      • À̽º¶ó¿¤
      • ±âŸ Áßµ¿
  • ¾ÆÇÁ¸®Ä«
      • ºÏ¾ÆÇÁ¸®Ä«
      • Áß¾Ó¾ÆÇÁ¸®Ä«
      • ³²¾ÆÇÁ¸®Ä«

Á¦10Àå °æÀï ±¸µµ

  • Thermo Fisher Scientific
  • Danaher
  • PerkinElmer
  • BD
  • Bio-Rad Laboratories
  • Agilent Technologies
  • Illumina
  • Luminex
  • Merck KGaA
  • GE Healthcare
  • Bruker
  • Nanostring Technologies
  • 10x Genomics
  • Fluidigm
  • Celsee
  • Berkeley Lights
  • Miltenyi Biotec
  • Bionano Genomics
  • Bio-Techne
  • Sphere Fluidics

Á¦11Àå ¼½¼Ç

  • Á¶»ç ¹æ¹ý
  • ÃâÆÇ»ç¿¡ ´ëÇØ
LSH 25.06.23

High End Cellomics Market is estimated to be valued at USD 4.64 Bn in 2025 and is expected to reach USD 8.54 Bn by 2032, growing at a compound annual growth rate (CAGR) of 9.1% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 4.64 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 9.10% 2032 Value Projection: USD 8.54 Bn

The high end cellomics market is experiencing significant growth and has become a key focus area in the field of cellular analysis and research. High end cellomics refers to the advanced technologies and instruments used for the study of cells at a molecular level. These technologies enable scientists and researchers to analyze cell structure, function, and dynamics, leading to important advancements in various fields such as drug discovery, disease diagnosis, and personalized medicine.

High end cellomics has gained prominence due to the increasing demand for cell-based research and the need for precise and accurate analysis of cellular processes. Advancements in imaging technologies, such as high-resolution microscopy and high-content screening, have greatly contributed to the growth of the high end cellomics market. Additionally, the integration of artificial intelligence and machine learning algorithms have revolutionized the analysis and interpretation of complex cellular data.

Market Dynamics:

The high end cellomics market is driven by several factors including the increasing demand for personalized medicine and the growing focus on drug discovery and development. The rising prevalence of chronic diseases, such as cancer and cardiovascular disorders, further fuels the demand for advanced cell analysis technologies. Additionally, investments in research and development activities by pharmaceutical and biotechnology companies have significantly contributed to the market growth.

For instance, on October 26, 2023, A4cell, a research and technology company, announced a significant US$ 3.1 million investment. This significant investment will act as a catalyst to completely transform the field of live single-cell analysis. The investment will mainly go towards stepping up R&D efforts, growing their highly skilled staff of scientists and engineers, and quickening the development of cutting-edge technologies intended to reveal the mysteries concealed in live single cells.

However, the high end cellomics market also faces certain challenges. The high costs associated with the procurement and maintenance of advanced cell analysis instruments poses a barrier to market growth, especially in developing regions. Moreover, the lack of skilled professionals proficient in handling and analyzing complex cellular data hampers the widespread adoption of high end cellomics technologies.

Despite these challenges, the high end cellomics market presents numerous opportunities for growth. The emergence of new cellular analysis techniques, such as single-cell sequencing and spatial transcriptomics, opens avenues for further exploration and understanding of cellular mechanisms. Additionally, the integration of multi-omics data analysis and the development of innovative imaging modalities offer promising opportunities for market expansion.

Key Features of the Study:

  • This report provides an in-depth analysis of the global high end cellomics market including its market size (in US$ Bn) and compound annual growth rate (CAGR %) over the forecast period of 2025-2032, with 2024 as the base year
  • It elucidates potential revenue growth opportunities across different market segments and provides attractive investment proposition matrices for the high end cellomics market
  • The study offers key insights into market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players in the high end cellomics market
  • It profiles key players in the global high end cellomics market, highlighting their company backgrounds, product portfolios, key achievements, financial performance, and strategies
  • The report includes a comprehensive list of key companies covered in the study including Thermo Fisher Scientific, Danaher, PerkinElmer, BD, Bio-Rad Laboratories, Agilent Technologies, Illumina, Luminex, Merck KGaA, GE Healthcare, Bruker, Nanostring Technologies, 10x Genomics, Fluidigm, Celsee, Berkeley Lights, Miltenyi Biotec, Bionano Genomics, Bio-Techne, and Sphere Fluidics
  • Insights from this report will enable marketers and management authorities to make informed decisions regarding product launches, upgrades, market expansion, and marketing strategies
  • The report caters to various stakeholders in the high end cellomics market including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders will benefit from the strategy matrices used in the analysis of the global high end cellomics market, facilitating ease in decision-making

High End Cellomics Market Segmentation:

  • By Product Type
    • Instruments
    • Reagents and Consumables
    • Software
    • Services
  • By Application
    • Drug discovery
    • Cancer Research
    • Neuroscience
    • Stem Cell Research and Regenerative Medicine
    • Personalized Medicine
    • Others
  • By Technology
    • Microscopy
    • Flow Cytometry
    • Single-cell Genomics
    • Mass Spectrometry
    • Next Generation Sequencing
    • Others
  • By End User
    • Biotechnology & Pharmaceutical Companies
    • Hospitals & Diagnostic Laboratories
    • Contract Research Organizations
    • Others
  • By Region
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles
    • Thermo Fisher Scientific
    • Danaher
    • PerkinElmer
    • BD
    • Bio-Rad Laboratories
    • Agilent Technologies
    • Illumina
    • Luminex
    • Merck KGaA
    • GE Healthcare
    • Bruker
    • Nanostring Technologies
    • 10x Genomics
    • Fluidigm
    • Celsee
    • Berkeley Lights
    • Miltenyi Biotec
    • Bionano Genomics
    • Bio-Techne
    • Sphere Fluidics

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global High End Cellomics Market, By Product Type
    • Global High End Cellomics Market, By Application
    • Global High End Cellomics Market, By Technology
    • Global High End Cellomics Market, By End User
    • Global High End Cellomics Market, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
  • Increasing demand for personalized medicine
    • Restraints
  • High costs associated with the procurement and maintenance of advanced cell analysis instruments
    • Opportunities
  • Emergence of new cellular analysis techniques such as single-cell sequencing and spatial transcriptomics
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Global High End Cellomics Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global High End Cellomics Market, By Product Type, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Instruments
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Reagents & Consumables
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Software
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Services
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

6. Global High End Cellomics Market, By Application, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Drug discovery
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Cancer Research
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Neuroscience
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Stem Cell Research and Regenerative Medicine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Personalized Medicine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

7. Global High End Cellomics Market, By Technology, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Microscopy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Flow Cytometry
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Single-cell Genomics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Mass Spectrometry
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Next Generation Sequencing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

8. Global High End Cellomics Market, By End User, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Biotechnology & Pharmaceutical Companies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Hospitals & Diagnostic Laboratories
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Contract Research Organizations
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

9. Global High End Cellomics Market, By Region, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021-2032
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Bn)
      • U.S.
      • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Bn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Bn)
      • China
      • Japan
      • India
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Bn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Bn)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-region, 2020 - 2032, (US$ Bn)
      • North Africa
      • Central Africa
      • South Africa

10. Competitive Landscape

  • Thermo Fisher Scientific
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Danaher
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • PerkinElmer
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • BD
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Bio-Rad Laboratories
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Agilent Technologies
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Illumina
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Luminex
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Merck KGaA
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • GE Healthcare
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Bruker
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Nanostring Technologies
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • 10x Genomics
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Fluidigm
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Celsee
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Berkeley Lights
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Miltenyi Biotec
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Bionano Genomics
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Bio-Techne
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Sphere Fluidics
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Analyst Views

11. Section

  • Research Methodology
  • About us
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦